Pancreatic Cancer Research

ResearcherOtto-von-Guericke-Universität MagdeburgActive in the last 2 years

Inna N. Lavrik

ORCID-verified (high confidence)As of 15 November 2026

Matched on ORCID iD 0000-0002-9324-309X; OpenAlex author ID A5054417011.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 0, last author 2)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Labs led
1
Collaborators
2
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Pharmacological targeting of caspase-8/c-FLIPL heterodimer enhances complex II assembly and elimination of pancreatic cancer cells. Last author DOI 10.1038/s42003-024-07409-6↗
  2. Combinatorial treatment of CD95L and gemcitabine in pancreatic cancer cells induces apoptotic and RIP1-mediated necroptotic cell death network. Last author DOI 10.1016/j.yexcr.2015.10.005↗

Closest collaborators

The 2 strongest of 2 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Corinna König · 1 shared paper, 2025
  2. Sabine Pietkiewicz · 1 shared paper, 2015

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.